Robinhood shares gain on Q2 beat, as user and crypto growth accelerate
Investing.com - DR Horton (NYSE: DHI) reported first quarter EPS of $2.61, $0.23 better than the analyst estimate of $2.38. Revenue for the quarter came in at $7.61B versus the consensus estimate of $7.12B.
Guidance
DR Horton sees FY 2025 revenue of $36.00B-$37.50B versus the analyst consensus of $37.09B.
DR Horton's stock price closed at $147.65. It is down -19.18% in the last 3 months and down -6.37% in the last 12 months.
DR Horton saw 0 positive EPS revisions and 10 negative EPS revisions in the last 90 days. See DR Horton's stock price’s past reactions to earnings here.
According to InvestingPro, DR Horton's Financial Health score is "great performance".
Check out DR Horton's recent earnings performance, and DR Horton's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar